Ma. Weitzner et al., METHYLPHENIDATE IN THE TREATMENT OF NEUROBEHAVIORAL SLOWING ASSOCIATED WITH CANCER AND CANCER-TREATMENT, The Journal of neuropsychiatry and clinical neurosciences, 7(3), 1995, pp. 347-350
Psychostimulants used in the treatment psychiatric conditions, includi
ng depression, alleviate some of the observed psychomotor retardation.
We describe 3 patients with impairments of arousal and psychomotor sp
eed secondary to tumor-related organic brain dysfunction who benefited
from stimulant therapy.